
At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference.If this is your profile, we want to hear from you.
The Summer Pharmacy Intern in will support Market Access initiatives within Eisai, a biopharmaceutical organization. This twelve (12) week internship is designed to provide a Doctor of Pharmacy (PharmD) student with hands-on exposure to how clinical, economic, access, and patient support data are generated, analyzed, and applied to improve patient access and outcomes in oncology, neurology, and specialty care.
The intern will work cross-functionally with Patient Services, Medical Affairs, Market Access, HEOR & RWE, and other internal stakeholders to support projects related to patient access, reimbursement support programs, real-world data/pharmacoeconomics, and value communication.
Key Learning Objectives
Primary Responsibilities
Under the guidance and supervision of experienced leaders, the intern may support the following activities:
HEOR & Real World‑ Evidence Support
Patient Services & Access
Cross Functional‑ Collaboration
Required Qualifications
Preferred Qualifications
Professional Development Opportunities
Eisai Salary Transparency Language:
The hourly rate for the Summer Pharmacy Intern – Eisai Market Access (Hybrid) is : $25.
Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status.Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans.
Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Please click on the following link for more information:

At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US.
Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.